204 related articles for article (PubMed ID: 16846207)
1. Synthesis and properties of cyclopropane-derived peptidomimetics.
Reichelt A; Martin SF
Acc Chem Res; 2006 Jul; 39(7):433-42. PubMed ID: 16846207
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
[TBL] [Abstract][Full Text] [Related]
3. Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors.
Martin SF; Dorsey GO; Gane T; Hillier MC; Kessler H; Baur M; Mathä B; Erickson JW; Bhat TN; Munshi S; Gulnik SV; Topol IA
J Med Chem; 1998 May; 41(10):1581-97. PubMed ID: 9572884
[TBL] [Abstract][Full Text] [Related]
4. Cyclopropane-derived peptidomimetics. design, synthesis, and evaluation of novel Ras farnesyltransferase inhibitors.
Hillier MC; Davidson JP; Martin SF
J Org Chem; 2001 Mar; 66(5):1657-71. PubMed ID: 11262110
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2,3- and 3,4-methanoamino acid equivalents with stereochemical diversity and their conversion into the tripeptide proteasome inhibitor belactosin a and its highly potent cis-cyclopropane stereoisomer.
Yoshida K; Yamaguchi K; Sone T; Unno Y; Asai A; Yokosawa H; Matsuda A; Arisawa M; Shuto S
Org Lett; 2008 Aug; 10(16):3571-4. PubMed ID: 18642830
[TBL] [Abstract][Full Text] [Related]
6. Side reaction of significance in preparation of peptide- or peptidomimetic-based hydroxamate enzyme inhibitors.
Hesek D; Noll BC; Mobashery S
J Org Chem; 2006 Mar; 71(7):2885-7. PubMed ID: 16555848
[TBL] [Abstract][Full Text] [Related]
7. 1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors.
Martin SF; Austin RE; Oalmann CJ; Baker WR; Condon SL; deLara E; Rosenberg SH; Spina KP; Stein HH; Cohen J
J Med Chem; 1992 May; 35(10):1710-21. PubMed ID: 1588553
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of cyclopropane-containing leu-enkephalin analogs.
Dwyer MP; Martin SF
Methods Mol Med; 1999; 23():407-16. PubMed ID: 21380910
[TBL] [Abstract][Full Text] [Related]
9. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand.
Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG
Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617
[TBL] [Abstract][Full Text] [Related]
10. Convergent approach to (E)-alkene and cyclopropane peptide isosteres.
Wipf P; Xiao J
Org Lett; 2005 Jan; 7(1):103-6. PubMed ID: 15624988
[TBL] [Abstract][Full Text] [Related]
11. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
Mizuno A; Matsui K; Shuto S
Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
[TBL] [Abstract][Full Text] [Related]
12. Beta-amino acid-containing hybrid peptides--new opportunities in peptidomimetics.
Aguilar MI; Purcell AW; Devi R; Lew R; Rossjohn J; Smith AI; Perlmutter P
Org Biomol Chem; 2007 Sep; 5(18):2884-90. PubMed ID: 17728852
[TBL] [Abstract][Full Text] [Related]
13. Cyclopropane-Based Peptidomimetics Mimicking Wide-Ranging Secondary Structures of Peptides: Conformational Analysis and Their Use in Rational Ligand Optimization.
Mizuno A; Kameda T; Kuwahara T; Endoh H; Ito Y; Yamada S; Hasegawa K; Yamano A; Watanabe M; Arisawa M; Shuto S
Chemistry; 2017 Mar; 23(13):3159-3168. PubMed ID: 28000361
[TBL] [Abstract][Full Text] [Related]
14. Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
Gilleron P; Millet R; Houssin R; Wlodarczyk N; Farce A; Lemoine A; Goossens JF; Chavatte P; Pommery N; Hénichart JP
Eur J Med Chem; 2006 Jun; 41(6):745-55. PubMed ID: 16647166
[TBL] [Abstract][Full Text] [Related]
15. Peptidomimetics: Fmoc solid-phase pseudopeptide synthesis.
Cudic P; Stawikowski M
Methods Mol Biol; 2008; 494():223-46. PubMed ID: 18726577
[TBL] [Abstract][Full Text] [Related]
16. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
17. Solution and solid-supported synthesis of 3,4,5-trisubstituted 1,2,4-triazole-based peptidomimetics.
Boeglin D; Cantel S; Heitz A; Martinez J; Fehrentz JA
Org Lett; 2003 Nov; 5(23):4465-8. PubMed ID: 14602026
[TBL] [Abstract][Full Text] [Related]
18. Stereocontrolled synthesis of methyl silanediol peptide mimics.
Nielsen L; Lindsay KB; Faber J; Nielsen NC; Skrydstrup T
J Org Chem; 2007 Dec; 72(26):10035-44. PubMed ID: 18001103
[TBL] [Abstract][Full Text] [Related]
19. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
Tsantrizos YS
Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
[TBL] [Abstract][Full Text] [Related]
20. Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action.
Kawamura S; Unno Y; List A; Mizuno A; Tanaka M; Sasaki T; Arisawa M; Asai A; Groll M; Shuto S
J Med Chem; 2013 May; 56(9):3689-700. PubMed ID: 23547757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
